PALISEUL PHARMA
The computed 12-month bankruptcy probability of PALISEUL PHARMA is 0.7% (low). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 21 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 23-06-2025 | 2025-00171649 |
| 31-12-2023 | volledig | 04-07-2024 | 2024-00210270 |
| 31-12-2022 | volledig | 26-07-2023 | 2023-00280528 |
| 31-12-2021 | volledig | 15-07-2022 | 2022-20190400 |
| 31-12-2020 | volledig | 09-07-2021 | 2021-33900299 |
| 31-12-2019 | volledig | 16-07-2020 | 2020-31100177 |
| 31-12-2018 | volledig | 18-06-2019 | 2019-19600169 |
| 31-12-2017 | volledig | 21-06-2018 | 2018-21200564 |
| 31-12-2016 | volledig | 07-07-2017 | 2017-29200032 |
| 31-12-2015 | volledig | 30-07-2016 | 2016-38900357 |
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 07-07-2005 |
| Status | Active |
| Postal code | 6850 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 84050A0135/00F000 | Wallonia | 362 m² | 1 · 185 m² | 11.9 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
09-02-2024 Change in the board of directors
Technical details
{
"events": [],
"notary": {
"name": "Caroline BOUILLON",
"firm_city": null,
"firm_name": null,
"office_city": "Bouillon",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-09",
"filing_date": "2024-02-07",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-01-25",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0874.952.569",
"name_full": "PHARMACIE VANHEMMENS",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Caroline BOUILLON",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"exp\u00E9dition conforme d\u00E9livr\u00E9e avant enregistrement",
"statuts coordonn\u00E9s"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PALISEUL PHARMA |